Sponsored

Roche Information Solutions India helps build the future of Healthcare Industry

CXOToday has engaged in an exclusive interview with  Mr. Raja Jamalamadaka – Managing Director, Roche Information Solutions India Pvt. Ltd.

 

  1. How is Roche assisting the overall transformation of the healthcare technology sector?

Ans – Digitalization has been rapidly making its way through the healthcare industry. Roche, a-125-year-old pioneer in pharma and diagnostics, is now leveraging this digitalization wave to develop digital solutions to revolutionize healthcare delivery.

Our Pune-based Roche Information Solutions India Pvt. Ltd. has been developing cutting-edge solutions to assist healthcare professionals in meeting current and future expectations. We, at Roche, have been utilizing data analytics and workflow integration to gather both operational and clinical data and transform that data into actionable insights for fact-based clinical and patient decision-making.

 

  1. What kinds of growth strategies are RIS India and Roche considering? Has the parent firm made any adjustments to its strategy?

Ans – Roche’s vision for a sustainable Digital Healthcare Business led to the formation of Roche Information Solutions (RIS).

The RIS India site at Pune is a key digital center within the Roche world. While initially focused exclusively on Roche Information Solutions, the Pune site has now spread its wings across all of Roche, positioning itself as a “one-stop” digital shop for all Roche business units. This has led to more internal Roche digital teams starting off their operations at Pune.

As a result of the ensuing growth, the Roche Information Solutions India site at Pune will be Roche’s largest footprint in India by the end of 2023. Currently, three business units- Roche Information Solutions, Integrated Informatics, and the R&D teams of Roche Diagnostic Solutions are co-located in Pune.

 

  1. How committed is India to healthcare technology, and what part is Roche playing in that commitment?

Ans – India, with its highly skilled technology talent pool, large pool of English-speaking population and best-in-class engineering studies, has always been the preferred choice for organizations looking to leverage digital talent worldwide. At Roche, we intend to leverage this talent base and provide them a platform to develop cutting-edge healthcare digital solutions. We also aim to coach these bright professionals to become digital thought leaders of tomorrow in the health-tech space, through a combination of professional development opportunities, access to media platforms, opportunities for patenting, publishing of white papering, and access to coaching and mentorship from top healthcare technology professionals across the Roche world.

 

  1. The roadmap for RIS India for 2023 and the assistance that the international team would offer to promote general growth

Ans – We have two focus areas in 2023 at RIS India: diversification and thought leadership.

The focus on diversification, in 2023, will be along two dimensions –

a. Diversity Equality and Inclusion – Roche, as an organization takes great pride in its dedication to diversity. We are dedicated to DEI in all of its manifestations, but particularly to the diversity of ethnicity, culture, thought, and gender. Roche is assisting RIS India in implementing the DEI best practices, participating in international events, and receiving mentoring from leading Roche DEI specialists as part of this program.

b. Diversity of teams in Pune site – Real innovation results from the cross-pollination of concepts developed by outstanding people from numerous teams with various viewpoints, working together on global solutions. Our goal at RIS India is to promote this innovative by assisting several Roche global digital business units to establish their own teams in Pune and then having these teams collaborate together.

The thought leadership focus will manifest itself as:

c. Patenting, paper publishing – RIS India is a digital center of excellence that hires some of the best digital professionals that develop cutting edge products using innovative methodologies. RIS India will focus its efforts in 2023 on ensuring these innovations result in patents and published papers in reputed journals – taking steps towards establishing our professionals – and RIS India itself – as thought leaders in healthcare digital space.

d. Speaking at reputed fora/whitepapers in reputed technical journals – In 2023, we expect to see more of our professionals invited as industry experts to speak at reputed industry forums.

The global Roche office is supporting RIS India through major investments in facility, in access to Roche IP, in flying in top professionals like Roche’s global Chief Software Engineer to support such initiatives and partnerships with academic and industry forums.

 

5.What factors led to Roche’s third business vertical’s emergence, including Roche’s strong emphasis on research, keeping current, and establishing a sustainable business?

Ans – The digitalization of the healthcare sector has been slower than the other sectors. However, our industry has reached a turning point thanks to improvements in innovative technology and the accessibility of important data at scale. The digital transformation of healthcare is poised to intensify at this time.

By harnessing digital insights and stepping up collaboration, we could close inequality gaps and improve the health of each individual through timely individualized decisions. This is not only about data, but creating better outcomes for all. With Roche’s rich heritage in healthcare innovation and care reinvention, Roche leveraged diagnostic data to inform decisions and improve efficiencies in labs and clinics. Armed with new technologies and backed by investment in infrastructure, Roche is applying this experience, expertise and creativity to the digital space.

We are building on trusted relationships with organizations — large and small, from point of care to laboratory diagnostics, hospitals and the home. With our science-based approach, deep and broad medical expertise, extensive experience protecting confidential patient data and proven legacy of developing clinically-relevant technologies, Roche is in a unique position to drive this change in a sustainable way.

Leave a Response